“Path to Commercialization: Autologous Neural Stem Cell Therapies for Neurodegenerative Diseases

In Clinical Development, Featured on App, Orphan Drug Congress by Freya SmaleLeave a Comment

Teresa Leezer of RhinoCyte, Inc.   joined us for World Orphan Drug Congress USA 2015 to present about ‘ Autologous Neural Stem Cell Therapies for Neurodegenerative Diseases’ 
Download the presentation here to understand more about:

  • RhinoCyte key product attributes
  • Investigational New Drug (IND) Submission in Spinal Cord Injury
  • Phase I/II Multi-center Trial
  • RhinoCyte Financial Status
  • Value Proposition
…and much more!
Get your copy here!
To find out more about how RhinoCyte is working to commercialize autologous neural stem cell therapies for neurodengerative diseases , join us at  World Orphan Drug Congress USA 2016 April 20-22  in Washington, DC.

Leave a Comment